Geode Capital Management
IMNM icon

Geode Capital Management’s Immunome IMNM Stock Holding History

Geode Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56M Buy
2,560,664
+199,283
+8% +$4.44M ﹤0.01% 1431
2025
Q4 		$50.7M Buy
2,361,381
+466,806
+25% +$8.19M ﹤0.01% 1473
2025
Q3 		$22.2M Buy
1,894,575
+33,995
+2% +$338K ﹤0.01% 1947
2025
Q2 		$17.3M Buy
1,860,580
+117,523
+7% +$964K ﹤0.01% 2028
2025
Q1 		$11.7M Buy
1,743,057
+514,206
+42% +$4.93M ﹤0.01% 2196
2024
Q4 		$13.1M Buy
1,228,851
+21,396
+2% +$259K ﹤0.01% 2195
2024
Q3 		$17.7M Buy
1,207,455
+144,557
+14% +$2.05M ﹤0.01% 2043
2024
Q2 		$12.9M Buy
1,062,898
+630,419
+146% +$9.86M ﹤0.01% 2172
2024
Q1 		$10.7M Buy
432,479
+111,641
+35% +$2.27M ﹤0.01% 2284
2023
Q4 		$3.43M Buy
320,838
+236,130
+279% +$1.96M ﹤0.01% 2885
2023
Q3 		$708K Buy
84,708
+3,495
+4% +$25.7K ﹤0.01% 3467
2023
Q2 		$642K Hold
81,213
– – ﹤0.01% 3542
2023
Q1 		$405K Hold
81,213
– – ﹤0.01% 3727
2022
Q4 		$178K Sell
81,213
-193
-0.2% -$778 ﹤0.01% 4158
2022
Q3 		$361K Hold
81,406
– – ﹤0.01% 3902
2022
Q2 		$261K Hold
81,406
– – ﹤0.01% 4107
2022
Q1 		$462K Buy
81,406
+1,438
+2% +$10.8K ﹤0.01% 3971
2021
Q4 		$1.04M Buy
79,968
+25,299
+46% +$451K ﹤0.01% 3704
2021
Q3 		$1.33M Buy
54,669
+15,140
+38% +$264K ﹤0.01% 3535
2021
Q2 		$683K Sell
39,529
-9,802
-20% -$217K ﹤0.01% 3791
2021
Q1 		$1.67M Buy
49,331
+34,151
+225% +$849K ﹤0.01% 3341
2020
Q4 		$146K Buy
+15,180
New +$177K ﹤0.01% 3980

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Geode Capital Management's IMNM Position: Q1 2026 in Review

Geode Capital Management increased its Immunome (IMNM) stake by 8.4% in Q1 2026, buying an estimated $4.44M and bringing the position to 2,560,664 shares worth $56M. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

Geode Capital Management first reported a position in IMNM in Q4 2020 and has held it in 22 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Geode Capital Management held 2,560,664 shares of Immunome worth $56M as of Q1 2026.
  • Geode Capital Management bought 199,283 Immunome shares in Q1 2026, an estimated $4.44M.
  • Immunome made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #1431 holding.
  • Geode Capital Management first reported a position in Immunome in Q4 2020 and has held it in 22 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.